fintopic.
Docs Get the API

Samsung Biologics price targets lowered by Hana and Daol

2 statements from 2 sources on Oct 5, 2026, 22:55–23:29 UTC
News
Updated
207940.KS
Front page

Statements (2)

  1. Bearish

    Daol Investment Securities lowered its Samsung Biologics price target from 2.1 million won to 2.0 million won

    yna.co.kr
  2. Bearish

    Hana Securities lowered its Samsung Biologics price target from 2.03 million won to 1.95 million won

    mk.co.kr